selected publications
- Real-world Outcomes of Cyclin-dependent Kinase Inhibitors Continued Beyond First Disease Progression in Hormone Receptor-positive Metastatic Breast Cancer. Clinical breast cancer. 2020 Academic Article GET IT
-
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2020
Academic Article
GET IT
Times cited: 54 -
Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update.
Archives of pathology & laboratory medicine.
2020
Academic Article
GET IT
Times cited: 17 -
Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy.
Breast cancer research and treatment.
2019
Review
GET IT
Times cited: 11 -
Revisiting the Role of Bevacizumab in the Treatment of Breast Cancer.
Seminars in oncology.
2017
Review
GET IT
Times cited: 9 - Analysis of Origins of Admission for Solid Tumor Oncology Inpatients: Disease Severity and Outcomes. Journal of oncology practice. 2017 Conference Paper GET IT
- Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families. Familial cancer. 2016 Academic Article GET IT
-
Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma.
The Journal of urology.
2010
Academic Article
GET IT
Times cited: 98 -
Emerging drugs for renal cell carcinoma.
Expert opinion on emerging drugs.
2010
Review
GET IT
Times cited: 6